Search Results - David M. Faleck

  • Showing 1 - 3 results of 3
Refine Results
  1. 1

    IL12/23 Blockade with Ustekinumab as a Treatment for Immune-Related Cutaneous Adverse Events by Stephanie L. Gu, Tara Maier, Andrea P. Moy, Stephen Dusza, David M. Faleck, Neil J. Shah, Mario E. Lacouture

    Published in Pharmaceuticals (2023-11-01)
    Get full text
    Article


  2. 2

    Concurrent immune checkpoint inhibition and selective immunosuppressive therapy in patients with immune-related enterocolitis by Wei Qiao, John A Thompson, Hamzah Abu-Sbeih, Yinghong Wang, Michael Dougan, Mehmet Altan, Michael A Postow, Yousef R Badran, Fangwen Zou, Anusha S Thomas, Sienna M Durbin, Barbara E Dutra, Donna E Leet, Po-Ying Lai, Nora K Horick, David M Faleck

    Published in Journal for ImmunoTherapy of Cancer (2023-06-01)
    Get full text
    Article


  3. 3

    Polygenic risk score for ulcerative colitis predicts immune checkpoint inhibitor-mediated colitis by Pooja Middha, Rohit Thummalapalli, Michael J. Betti, Lydia Yao, Zoe Quandt, Karmugi Balaratnam, Cosmin A. Bejan, Eduardo Cardenas, Christina J. Falcon, David M. Faleck, Princess Margaret Lung Group, Matthew A. Gubens, Scott Huntsman, Douglas B. Johnson, Linda Kachuri, Khaleeq Khan, Min Li, Christine M. Lovly, Megan H. Murray, Devalben Patel, Kristin Werking, Yaomin Xu, Luna Jia Zhan, Justin M. Balko, Geoffrey Liu, Melinda C. Aldrich, Adam J. Schoenfeld, Elad Ziv

    Published in Nature Communications (2024-03-01)
    Get full text
    Article


Search Tools: